8/23/2013 9:35:12 AM
At the extra general meeting (EGM) in ChronTech Pharma AB on the 16th of May
it was resolved to accept the board’s proposal for restructuring of the company
and transfer of the Company’s projects regarding development of DNA-vaccines
against hepatitis B and hepatitis C.
Help employers find you! Check out all the jobs and post your resume.
comments powered by